420 with CNW — Senators Express Disappointment with

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
192
420 with CNW — Senators Express Disappointment with President Biden’s Failure to Enact Marijuana Reforms

President Joseph Biden based part of his campaign on marijuana reform, stating that he would pursue marijuana decriminalization and the expungement of prior cannabis-related offenses. However, one-and-a-half years after he took office, the Biden administration has barely taken any action to keep the president’s marijuana promises. This inaction has been met with criticism and disappointment from drug reform activists and lawmakers.

Six U.S. senators recently renewed their call for the president to fulfill his cannabis promises, specifically de-scheduling cannabis and granting mass pardons to people currently incarcerated for cannabis offenses. Furthermore, they said that the Justice Department’s response to a letter the lawmakers sent in October 2021 was “extraordinarily disappointing.”

Sens Bernie Sanders, Elizabeth Warren, Cory Booker, Ed Markley, Kirsten Gillibrand and Ed Markey were signatories to the new letter sent to the president, Human Services (HHS) secretary Xavier Becerra, and Attorney General Merrick Garland.

They requested that the attorney general remove marijuana from the Controlled Substances Act (CSA) and that \ Biden issue mass pardons to people who were convicted for nonviolent federal cannabis offences. According to the senators, it took the DOJ a whopping six months to reply to the letter the y sent last October asking the attorney general to use his power to independently begin the process of removing cannabis from the CSA.

The ‘half-page response’ they received this April was extraordinarily disappointing, the senators wrote in the new letter. As per the April 2022 letter, the DOJ stated that the HHS still hadn’t determined that cannabis could be a safe and effective treatment option, hence its inaction. But the senators argued in their most recent letter that this ignored the fact that the DOJ and the Drug Enforcement Administration (DEA) had the power to start the de-scheduling process without the HHS’s input.

They say that the Controlled Substances Act empowers Attorney General Garland to request a scientific review from the HHS. Even if Human Services recommends that cannabis remain a Schedule I controlled substance or move to a lower schedule, the attorney general could still start the process of removing cannabis from the CSA. As such, the DOJ does not need a determination from the HHS to begin the de-scheduling process, the senators said, and research has already proven that cannabis does have medical benefits.

A coalition of senators, including Senators Warren and Markey sent Biden a letter in November 2021 urging him to grant mass clemency to people with federal cannabis convictions. However, the administration still hasn’t responded to the letter to date. The recent letter stated that while Biden’s efforts to grant pardons to 78 people were commendable, his administration needed to do much more to handle the situation

The entire cannabis industry, including entities such as Flora Growth Corp. (NASDAQ: FLGC), is also wondering when the federal government will ever wake up and recognize that science has proven that marijuana does possess medical benefits and that many patients see it as a godsend.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Flora Growth Corp. (FLGC) Stock Research Links

FLGC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Castle Biosciences Unveils Key Data on TissueCypher at ACG

Updated Category News Views 289

New Insights from Castle Biosciences at Annual Meeting Castle Biosciences, Inc. (NASDAQ: CSTL) recently highlighted groundbreaking research at a prestigious conference, showcasing its innovative TissueCypher Barrett's Esophagus test. This test provides critical risk insights that go beyond traditional pathology, influencing clinical management for early intervention in...

Continue Reading
Ben Foster Takes Charge as Chair of Rural Broadband Board

Updated Category News Views 97

Announcement of Ben Foster's Chair Appointment In a significant development for rural connectivity, Ben Foster, President and CEO of Twin Valley, has been appointed as the chair of the National Rural Broadband Association (NTCA). As a leader of Kansas' largest independently owned broadband and communications company, Foster's new role marks an important step for improving...

Continue Reading
Interoil's Bond Payment Restructuring Proposal Explained

Updated Category News Views 260

Interoil's Bond Payment Restructuring Proposal Interoil Exploration and Production ASA (the "Company") has initiated a process with Nordic Trustee AS to gather bondholders for a written resolution. This action concerns the senior secured callable bonds identified by ISIN NO 001 0729908 (the "Bonds"). Purpose of the Written Resolution The primary goal of this resolution is...

Continue Reading
DoubleLine Income Solutions Fund Announces Upcoming Distribution

Updated Category News Views 103

DoubleLine Income Solutions Fund Declares Distribution The DoubleLine Income Solutions Fund (the "Fund"), recognized under the symbol DSL on the New York Stock Exchange, has announced a forthcoming distribution of $0.11 per share. It’s important for investors to stay informed about the timing and details of these distributions. Distribution Overview This distribution...

Continue Reading
Interoil Reports October Production Growth and Updates

Updated Category News Views 118

Key Production Metrics and Overview Interoil Exploration and Production ASA has recently released its production metrics, showcasing a notable improvement in operational output for October. The total operated production in October averaged 2,239 barrels of oil equivalent per day (boepd), representing an increase of 157 boepd from the previous month. This positive trend...

Continue Reading